We provide you with 20 years of free, institutional-grade data for LQDA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of LQDA. Explore the full financial landscape of LQDA stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2020-11-06 | 1330436 | LQDA | 10-Q | Url |
| 2020-08-10 | 1330436 | LQDA | 10-Q | Url |
| 2020-05-11 | 1330436 | LQDA | 10-Q | Url |
| 2020-03-16 | 1330436 | LQDA | 10-K | Url |
| 2019-11-13 | 1330436 | LQDA | 10-Q | Url |
| 2019-08-14 | 1330436 | LQDA | 10-Q | Url |
| 2019-05-02 | 1330436 | LQDA | 10-Q | Url |
| 2019-03-18 | 1330436 | LQDA | S-1 | Url |
| 2019-02-26 | 1330436 | LQDA | 10-K | Url |
| 2018-10-31 | 1330436 | LQDA | 10-Q | Url |
| 2018-08-14 | 1330436 | LQDA | 10-Q | Url |
| 2018-06-28 | 1330436 | LQDA | S-1 | Url |
Liquidia Corporation(NASDAQ:LQDA) 
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include LIQ861, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension; ...
Website: http://www.liquidia.com
Founded: 2004
Full Time Employees: 64
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about LQDA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.